Electromed, Inc. (NYSE:ELMD) Shares Acquired by State Street Corp

State Street Corp boosted its position in Electromed, Inc. (NYSE:ELMD) by 14.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 22,066 shares of the company’s stock after acquiring an additional 2,800 shares during the quarter. State Street Corp owned 0.26% of Electromed worth $474,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in ELMD. Navellier & Associates Inc. acquired a new position in shares of Electromed during the third quarter worth $368,000. Walleye Capital LLC purchased a new stake in Electromed during the third quarter worth approximately $274,000. Gabelli Funds LLC boosted its holdings in Electromed by 7.8% in the second quarter. Gabelli Funds LLC now owns 38,675 shares of the company’s stock valued at $581,000 after purchasing an additional 2,808 shares in the last quarter. Marshall Wace LLP purchased a new position in Electromed in the second quarter valued at approximately $256,000. Finally, Pekin Hardy Strauss Inc. acquired a new stake in Electromed during the second quarter worth approximately $522,000. Hedge funds and other institutional investors own 40.82% of the company’s stock.

Electromed Trading Up 2.0 %

Shares of NYSE:ELMD opened at $30.69 on Friday. The firm has a 50 day simple moving average of $27.91 and a 200-day simple moving average of $21.01. Electromed, Inc. has a twelve month low of $9.81 and a twelve month high of $31.31. The company has a market capitalization of $259.58 million, a PE ratio of 42.63 and a beta of 0.31.

Electromed (NYSE:ELMD) last posted its earnings results on Tuesday, November 12th. The company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.13. The business had revenue of $14.67 million during the quarter. Electromed had a return on equity of 15.32% and a net margin of 11.34%.

Insider Activity

In other news, Director Andrew Summers sold 17,463 shares of the stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $30.09, for a total transaction of $525,461.67. Following the completion of the sale, the director now owns 189,838 shares in the company, valued at approximately $5,712,225.42. This represents a 8.42 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 14.00% of the company’s stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.